Exact Mass: 377.1843
Exact Mass Matches: 377.1843
Found 60 metabolites which its exact mass value is equals to given mass value 377.1843,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Gly Lys Ser Ser
(2S)-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid
Gly Ser Lys Ser
(2S)-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]hexanamido]-3-hydroxypropanoic acid
Gly Ser Ser Lys
(2S)-6-amino-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-hydroxypropanamido]hexanoic acid
Lys Gly Ser Ser
(2S)-2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-hydroxypropanamido]-3-hydroxypropanoic acid
Lys Ser Gly Ser
(2S)-2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]acetamido}-3-hydroxypropanoic acid
Lys Ser Ser Gly
2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]acetic acid
Ser Gly Lys Ser
(2S)-2-[(2S)-6-amino-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}hexanamido]-3-hydroxypropanoic acid
Ser Gly Ser Lys
(2S)-6-amino-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-hydroxypropanamido]hexanoic acid
Ser Lys Gly Ser
(2S)-2-{2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]acetamido}-3-hydroxypropanoic acid
Ser Lys Ser Gly
2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]-3-hydroxypropanamido]acetic acid
Ser Ser Gly Lys
(2S)-6-amino-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]acetamido}hexanoic acid
Ser Ser Lys Gly
2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]hexanamido]acetic acid
3-Dibenzylamino-2-fluoropropionic acid, benzyl ester
3-Dibenzylamino-2-fluoropropionic acid, benzyl ester
Propafenone hydrochloride
Propafenone hydrochloride
D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
4-Hydroxy-7-isopropyl-6-oxo-n-(3-(1-piperidinyl)propyl)-6,7-dihydrothieno(2,3-b)pyridine-5-carboxamide
4-Hydroxy-7-isopropyl-6-oxo-n-(3-(1-piperidinyl)propyl)-6,7-dihydrothieno(2,3-b)pyridine-5-carboxamide
Diethylaminoethyl diphenylhydroxypropionate hydrochloride
Diethylaminoethyl diphenylhydroxypropionate hydrochloride
2-{3-[4-(4-Fluorophenyl)-3,6-dihydro-1(2H)-pyridinyl]propyl}-8-methyl-4(3H)-quinazolinone
2-{3-[4-(4-Fluorophenyl)-3,6-dihydro-1(2H)-pyridinyl]propyl}-8-methyl-4(3H)-quinazolinone
2-[2-(1-Carboxyethylamino)ethylamino]-6-[(3-carboxy-3-hydroxypropanoyl)amino]hexanoic acid
2-[2-(1-Carboxyethylamino)ethylamino]-6-[(3-carboxy-3-hydroxypropanoyl)amino]hexanoic acid
N-(2-furanylmethyl)-3-(2,4,8,10-tetramethyl-3-pyrido[2,3]pyrazolo[2,4-a]pyrimidinyl)propanamide
N-(2-furanylmethyl)-3-(2,4,8,10-tetramethyl-3-pyrido[2,3]pyrazolo[2,4-a]pyrimidinyl)propanamide
3-[(2-fluorophenyl)methyl]-5-propyl-N-(pyridin-4-ylmethyl)-7-triazolo[4,5-d]pyrimidinamine
3-[(2-fluorophenyl)methyl]-5-propyl-N-(pyridin-4-ylmethyl)-7-triazolo[4,5-d]pyrimidinamine
5-ethyl-3-[(2-fluorophenyl)methyl]-N-[2-(2-pyridinyl)ethyl]-7-triazolo[4,5-d]pyrimidinamine
5-ethyl-3-[(2-fluorophenyl)methyl]-N-[2-(2-pyridinyl)ethyl]-7-triazolo[4,5-d]pyrimidinamine
2-methyl-4-(1-methyl-4-pyrazolyl)-N-(5-methyl-2-pyridinyl)-5-oxo-4a,6,7,8-tetrahydro-4H-quinoline-3-carboxamide
2-methyl-4-(1-methyl-4-pyrazolyl)-N-(5-methyl-2-pyridinyl)-5-oxo-4a,6,7,8-tetrahydro-4H-quinoline-3-carboxamide
Co 101244 (hydrochloride)
Co 101244 (hydrochloride)
Co 101244 (PD 174494) hydrochloride is a NR2B-containing NMDA receptor antagonist[1].
(1r,4e,6s,7r,17s)-4-ethylidene-6,7-dimethyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-7-yl acetate
(1r,4e,6s,7r,17s)-4-ethylidene-6,7-dimethyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-7-yl acetate
n-{3-[(2e)-n-{4-[(hydroxymethylidene)amino]butyl}-3-phenylprop-2-enamido]propyl}methylsulfanylcarboximidic acid
n-{3-[(2e)-n-{4-[(hydroxymethylidene)amino]butyl}-3-phenylprop-2-enamido]propyl}methylsulfanylcarboximidic acid
(1r,1'r,5s,6'r)-5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclohexane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione
(1r,1'r,5s,6'r)-5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclohexane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione
4-ethylidene-6,7-dimethyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-7-yl acetate
4-ethylidene-6,7-dimethyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-7-yl acetate
3-{2,4-dihydroxy-5-[(2e,4e)-n-(2-hydroxyethyl)-7-methylocta-2,4-dienamido]phenyl}propanoic acid
3-{2,4-dihydroxy-5-[(2e,4e)-n-(2-hydroxyethyl)-7-methylocta-2,4-dienamido]phenyl}propanoic acid
(1s,8s,10s,11r,12s,13s)-3,4,12-trimethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-triene-11,13-diol
(1s,8s,10s,11r,12s,13s)-3,4,12-trimethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-triene-11,13-diol
(1r,4e,6r,7r,17r)-4-ethylidene-6,7-dimethyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-7-yl acetate
(1r,4e,6r,7r,17r)-4-ethylidene-6,7-dimethyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-7-yl acetate
methyl (1s,3r,4s,11s,13s,14e)-3,4-dimethoxy-14-(2-methoxy-2-oxoethylidene)-9-azatetracyclo[7.5.0.0¹,⁶.0¹¹,¹³]tetradec-5-ene-13-carboxylate
methyl (1s,3r,4s,11s,13s,14e)-3,4-dimethoxy-14-(2-methoxy-2-oxoethylidene)-9-azatetracyclo[7.5.0.0¹,⁶.0¹¹,¹³]tetradec-5-ene-13-carboxylate
2-[2,6-dihydroxy-3,8-dimethylidene-4-(pyrrolidine-2-carbonyloxy)-octahydroazulen-5-yl]prop-2-enoic acid
2-[2,6-dihydroxy-3,8-dimethylidene-4-(pyrrolidine-2-carbonyloxy)-octahydroazulen-5-yl]prop-2-enoic acid
3,4,12-trimethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-triene-11,13-diol
3,4,12-trimethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-triene-11,13-diol
(1r,3s,5r,6s)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoate
(1r,3s,5r,6s)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoate
5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclohexane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione
5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclohexane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione
n-[3-(n-{4-[(hydroxymethylidene)amino]butyl}-3-phenylprop-2-enamido)propyl]methylsulfanylcarboximidic acid
n-[3-(n-{4-[(hydroxymethylidene)amino]butyl}-3-phenylprop-2-enamido)propyl]methylsulfanylcarboximidic acid
(1s,8s,10s,11r,12s,13s)-4,11,12-trimethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-triene-3,13-diol
(1s,8s,10s,11r,12s,13s)-4,11,12-trimethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-triene-3,13-diol
(2s)-6-[(3-carboxy-1,3-dihydroxypropylidene)amino]-2-({2-[(1-carboxyethyl)amino]ethyl}amino)hexanoic acid
(2s)-6-[(3-carboxy-1,3-dihydroxypropylidene)amino]-2-({2-[(1-carboxyethyl)amino]ethyl}amino)hexanoic acid
6-[(3-carboxy-1,3-dihydroxypropylidene)amino]-2-({2-[(1-carboxyethyl)amino]ethyl}amino)hexanoic acid
6-[(3-carboxy-1,3-dihydroxypropylidene)amino]-2-({2-[(1-carboxyethyl)amino]ethyl}amino)hexanoic acid
2-[(2s,3ar,4r,5r,6s,8ar)-2,6-dihydroxy-3,8-dimethylidene-4-[(2s)-pyrrolidine-2-carbonyloxy]-octahydroazulen-5-yl]prop-2-enoic acid
2-[(2s,3ar,4r,5r,6s,8ar)-2,6-dihydroxy-3,8-dimethylidene-4-[(2s)-pyrrolidine-2-carbonyloxy]-octahydroazulen-5-yl]prop-2-enoic acid
3-{2,4-dihydroxy-5-[n-(2-hydroxyethyl)-7-methylocta-2,4-dienamido]phenyl}propanoic acid
3-{2,4-dihydroxy-5-[n-(2-hydroxyethyl)-7-methylocta-2,4-dienamido]phenyl}propanoic acid
methyl 3,4-dimethoxy-14-(2-methoxy-2-oxoethylidene)-9-azatetracyclo[7.5.0.0¹,⁶.0¹¹,¹³]tetradec-5-ene-13-carboxylate
methyl 3,4-dimethoxy-14-(2-methoxy-2-oxoethylidene)-9-azatetracyclo[7.5.0.0¹,⁶.0¹¹,¹³]tetradec-5-ene-13-carboxylate
